Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Merck Reaffirms Commitment To Consumer Care In Restructuring

This article was originally published in The Tan Sheet

Executive Summary

Merck says it remains committed to retaining consumer care and animal health, though it continues to evaluate the businesses. Competitors such as Pfizer and Bristol-Myers Squibb successfully spun out non-pharma assets following similar restructurings.


Related Content

Merck Singulair Switch NDA Limits Indication To Allergies, Omits Asthma
Merck Singulair Switch NDA Limits Indication to Allergies, Omits Asthma
“Likely” Merck Consumer Health Sale Could Bring $8 Billion – Analysts
“Likely” Merck Consumer Health Sale Could Bring $8 Billion – Analysts
In Brief: Furness in new CDER role; Oxytrol for Women at retail; advisories on drug-tainted sex enhancers; senators want energy drink restrictions
FDA Needs More Time To Review Sugammadex Inspection Report, Cancels Advisory Committee
Consumer Division Divestments Would Spotlight Firms’ Value – Analysts
Merck Appoints Consumer Head To Help Division Expand Globally
Pfizer’s Wyeth Buy Rebuilds OTC Switch Potential
BMS Spins Off Mead Johnson In IPO, Retaining Majority Control


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts